Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-FDG-PET/Low-Dose CT
British Journal of Radiology · 13.11.2026
DOI: 10.1093/bjr/tqag273 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 13.11.2026. Verfasst von Frederikke Engel Høi-Hansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the prevalence and clinical significance of incidental findings (IF) detected by Total-body 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in a genuinely asymptomatic cohort of blood donors.
Methods
117 healthy, asymptomatic blood donors underwent ultra-low-dose FDG-PET/low-dose CT. The primary objective was to create an atlas of glucose metabolism in healthy individuals. A secondary objective was to assess the frequency and nature of IF, informing future considerations of the clinical value of potential screening programs. Here we report on IF.
Results
IF were detected in 64 participants (55%), with 51 (44%) presenting clinically insignificant IF and 13 (11%) clinically significant IF. Common insignificant IF included benign or inflammatory metabolic activity in the esophagus or lung parenchyma (n = 19), metabolically active reactive lymph nodes (n = 14), and degenerative skeletal changes (n = 13). Clinically significant IF comprised pathologically metabolically active cysts and polyps (n = 8), significantly enlarged vessels (n = 1), suspected malignant tumors (n = 1), large lipomas (n = 1), sarcoidosis (n = 1), and liver steatosis (n = 1).
Conclusions
This is the first study to systematically investigate incidental findings in an asymptomatic cohort using ultra-low-dose total-body FDG-PET/CT. Even in this highly selected population, numerous IFs were revealed, underscoring the need for risk-stratified, data-driven screening strategies integrating genetic biomarkers identifying individuals who will truly benefit. Advances in knowledge This first study of ultra-low-dose total-body FDG-PET/CT in asymptomatic donors found frequent incidental findings (55%, 11% clinically significant), establishing lower-bound estimates and supporting risk-stratified screening approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
- Board of Management, Rigshospitalet, Copenhagen, Denmark.
Zitieren
APA
Høi-Hansen, F. E., Hinge, C., Johannesen, H. H., Albrecht-Beste, E., Mikkelsen, C., Ostrowski, S. R., Fischer, B. M., Andersen, F. L., & Korsholm, K. (2026). Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-FDG-PET/Low-Dose CT. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag273
Vancouver
Høi-Hansen FE, Hinge C, Johannesen HH, Albrecht-Beste E, Mikkelsen C, Ostrowski SR, et al. Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-FDG-PET/Low-Dose CT. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag273
BibTeX
@article{HiHansen2026,
author = {Høi-Hansen, Frederikke Engel and Hinge, Christian and Johannesen, Helle Hjorth and Albrecht-Beste, Elisabeth and Mikkelsen, Christina and Ostrowski, Sisse Rye and Fischer, Barbara Malene and Andersen, Flemming Littrup and Korsholm, Kirsten},
title = {Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-FDG-PET/Low-Dose CT},
journal = {British Journal of Radiology},
year = {2026},
doi = {10.1093/bjr/tqag273}
}
EUVIMED